Clinical Trial Update: Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/Phase 2 safety and efficacy study of OPA-6566 Ophthalmic Solution in subjects with primary open-angle glaucoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• OPA-6566 Ophthalmic Solution (OPA-6566)

Snippet

Sponsor: Kubota Vision Inc. | Conditions: Primary Open-angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED